化瘀明目合剂辅助治疗糖尿病视网膜病变临床观察及对患者视力、糖脂代谢的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.2

基金项目:


Clinical Observation of Adjuvant Therapy of Huayu Mingmu Mixture on Diabetic Retinopathy and Its Effect on Visual Acuity and Glucose and Lipid Metabolism in Patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察化瘀明目合剂辅助治疗对糖尿病视网膜病(DR) 的临床疗效及其对患者视力、糖脂代谢的影响。方法:选取92 例DR 患者,按随机数字表法分为治疗组和对照组各46 例。对照组在常规降糖、降压、降脂等治疗的基础上加用羟苯磺酸钙胶囊治疗,治疗组在对照组的基础上加用化瘀明目合剂治疗。比较2 组治疗前后糖脂代谢、视力及眼部病变情况的变化,分析其临床疗效及不良发应发生率情况。结果:治疗组总有效率为95.65%,对照组为80.43%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组糖化血红蛋白(HbA1c)、空腹血糖(FBG)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C) 水平比较,差异无统计学意义(P>0.05);治疗后,2 组HbA1c、FBG、TG、LDL-C 水平均较治疗前降低,且治疗组HbA1c、FBG、TG、LDL-C 水平均低于对照组(P<0.05)。治疗前,2 组视力、黄斑中心凹厚度比较,差异无统计学意义(P>0.05)。治疗后,2 组视力、黄斑中心凹厚度均较治疗前改善(P<0.05);治疗组视力高于对照组,但差异无统计学意义(P>0.05);治疗组黄斑中心凹厚度低于对照组,差异有统计学意义(P<0.05)。治疗前,2 组血管瘤体积和视野灰度值、出血斑面积比较,差异无统计学意义(P>0.05);治疗后,2 组血管瘤体积、视野灰度值、出血斑面积均较治疗前降低(P<0.05),且治疗组上述指标均低于对照组(P<0.05)。治疗组不良反应发生率为8.70%,对照组为10.87%,2 组比较,差异无统计学意义(P>0.05)。结论:化瘀明目合剂辅助常规西药治疗DR 临床疗效显著,能有效改善血糖及血脂水平,提高患者视力,改善眼底病变,且无增加不良反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the adjuvant therapy of Huayu Mingmu mixture on diabetic retinopathy(DR) and its effect on vision acuity and glucose and lipid metabolism in patients. Methods:A total of 92 patients with DR were divided into the treatment group and the control group according to the random number table method,with 46 cases in each group. The control group was treated with calcium dobesilate capsules based on the routine hypoglycemic, anti- hypertensive and lipid- lowering treatments, and the treatment group was additionally treated with Huayu Mingmu mixture based on the treatment of the control group. The changes of glucose and lipid metabolism, visual acuity and eye condition before and after treatment were compared between the two groups, and the clinical effects and incidence of adverse reactions were analyzed. Results: The total effective rate was 95.65% in the treatment group and 80.43% in the control group,the difference being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of levels of glycosylated hemoglobin(HbA1c),fasting blood glucose(FBG),triglycerides(TG) and low-density lipoprotein cholesterol(LDL-C) between the two groups(P>0.05);after treatment,the above four levels in the two groups were decreased when compared with those before treatment,and the above levels in the treatment group were lower than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of visual acuity and central macular thickness between the two groups(P>0.05). After treatment,the visual acuity and central macular thickness in both groups were improved when compared with those before treatment(P<0.05);the visual acuity in the treatment group was higher than that in the control group, there being no significance in the difference(P>0.05); the central macular thickness in the treatment group was lower than that in the control group,the difference being significant(P< 0.05). Before treatment, there was no significant difference being found in the comparison of hemangioma volume, gray value of visual field and bleeding spot area between the two groups(P>0.05);after treatment,the above indexes in the two groups were decreased when compared with those before treatment(P<0.05),and the above indexes in the treatment group were lower than those in the control group(P<0.05). The incidence of adverse reactions was 8.70% in the treatment group and 10.87% in the control group,there being no significance in the difference(P>0.05). Conclusion:The therapy of Huayu Mingmu mixture assisting routine western medicine has a significant clinical effect on DR,which can effectively improve the blood glucose,regulate the level of blood lipid in the body,enhance the visual acuity in patients and improve fundus lesions, without increasing adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

罗贤令,方华.化瘀明目合剂辅助治疗糖尿病视网膜病变临床观察及对患者视力、糖脂代谢的影响[J].新中医,2022,54(10):147-150

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-05-24
  • 出版日期: